| Financial Year |
March 31 2023 |
| Monetary Funds |
1,060,975,064.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
4,368,214,690.42 |
| Advances to Suppliers |
10,714,141.62 |
| Other Receivables |
432,008,051.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
20,000,000.00 |
| Inventories |
12,673,400.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
304,241,787.22 |
| Total Current Assets |
6,609,910,595.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
384,286,001.25 |
| Investment Properties |
31,495,715.00 |
| Fixed Assetes |
9,274,015,666.17 |
| Under-construction Projects |
1,780,158,873.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,989,016,196.46 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,153,311.32 |
| Deferred Income Tax Assets |
135,973,346.81 |
| Other Non-Current Assets |
106,302,222.09 |
| Sub-Total of Non-Current Assets |
13,729,058,168.87 |
| Total Assets |
20,338,968,764.16 |
| Short-Term Loans |
1,869,359,832.79 |
| Trading Financial liabilities |
-- |
| Notes Payable |
26,000,000.00 |
| Accounts Payable |
2,018,213,224.44 |
| Accounts Received In Advance |
201,385.81 |
| Employee Compensation Payable |
104,599,842.99 |
| Taxes Payable |
8,813,123.05 |
| Interest Payable |
26,688,811.52 |
| Dividend Payable |
-- |
| Other payables |
344,549,930.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
989,436,883.53 |
| Other Current Liabilities |
611,974,772.87 |
| Sub-Total of Current Liabilities |
6,219,315,016.21 |
| Long-term Loans |
7,744,491,934.23 |
| Bonds Payable |
868,283,560.33 |
| Long-Term Accounts Payable |
146,230,682.70 |
| Special Payable |
-- |
| Estimatied Liabilities |
19,394,723.55 |
| Deferred Income Tax Liabilities |
15,359,447.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,830,996,496.03 |
| Total Liabilities |
15,050,311,512.24 |
| Paid-In Capital(Or Share Stock) |
709,569,692.00 |
| Capital Surplus |
860,270,578.76 |
| Surplus Reserve |
244,665,861.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,233,779,094.85 |
| Minority Stockholder's Interest |
221,892,667.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,066,764,584.07 |
| Owner's Equity（Stockholder's Equity） |
5,288,657,251.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,338,968,764.16 |
